Company intelligence / Profile preview
Turgut Pharmaceuticals
Istanbul, Istanbul, Turkey
- Ownership
- Private
- Employees
- ~99
- Development stage
- Other
01
Overview
Turgut Pharmaceuticals is a Turkish biopharmaceutical manufacturer focused on developing and producing biosimilar monoclonal antibodies and high‑tech small molecules, with at least five biosimilar mAb products under development and strategic alliances for cell line and process development; public sources emphasize R&D and manufacturing build‑out rather than completed pivotal clinical results, suggesting an advancing but still largely development‑stage biosimilar pipeline.[3][4][5][9][10][12]
- Therapeutic areas
- OncologyImmunologyRheumatologyHematology
- Modalities
- Monoclonal antibodyBiosimilarBiologicSmall molecule
- Industry
- Biotech
02
Drug pipeline
1 asset03
Partnerships
Selexis SA – multiple commercial license agreements for SUREtechnology Platform and SURE CHO-M Cell Line to develop several biosimilar monoclonal antibodies in oncology and inflammatory diseases[4][11][12]Merck Millipore (Merck KGaA’s life science arm) – strategic alliance for process development and manufacturing of monoclonal antibody biosimilars for non-small cell lung carcinoma and rheumatoid arthritis[10]KBI Biopharma – process development for first biosimilar mAb products[5]Covance (now part of Labcorp) – analytical method development and characterization studies for biosimilars[5]
Beyond the preview
Go deeper on Turgut Pharmaceuticals.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Turgut Pharmaceuticals.